| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 166641 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride | 0.0467178916101838 | 0.36073369 |
| NSC 191909 | .alpha.-Chloro-N-(p-methoxyphenyl)succinimide | 0.0467178916101838 | 0.40295996 |
| NSC 212446 | Null | 0.0467178916101838 | 0.44848387 |
| NSC 28365 | Null | 0.0467178916101838 | 0.39507086 |
| NSC 319447 | Null | 0.0467178916101838 | 0.3447451 |
| NSC 339578 | Null | 0.0467178916101838 | 0.22755801 |
| NSC 362454 | 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- | 0.0467178916101838 | 0.32311558 |
| NSC 606698 | Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt | 0.0467178916101838 | 0.12570094 |
| NSC 628561 | 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-dibutyl- | 0.0467178916101838 | 0.32953555 |
| NSC 723001 | Diethyl-N[4-(3-thienylquinoxalyn-2-yl)oxiphenylacetyl]-L-glu tamate | 0.046717891610184 | -0.12092263 |